Einar Stole

Array ( [id] => 4137799 [patent_doc_number] => 06060263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Mammalian lysophosphatidic acid acyltransferase' [patent_app_type] => 1 [patent_app_number] => 9/400742 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 8 [patent_no_of_words] => 14441 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060263.pdf [firstpage_image] =>[orig_patent_app_number] => 400742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126024 [patent_doc_number] => 06120771 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Mure' [patent_app_type] => 1 [patent_app_number] => 9/398165 [patent_app_country] => US [patent_app_date] => 1999-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12533 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/120/06120771.pdf [firstpage_image] =>[orig_patent_app_number] => 398165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248633 [patent_doc_number] => 06207430 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Nucleic acids encoding polypeptides having laccase activity' [patent_app_type] => 1 [patent_app_number] => 9/389528 [patent_app_country] => US [patent_app_date] => 1999-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 16325 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207430.pdf [firstpage_image] =>[orig_patent_app_number] => 389528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137813 [patent_doc_number] => 06060264 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Multiple drug resistance gene atrc of Aspergillus nidulans' [patent_app_type] => 1 [patent_app_number] => 9/352552 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9582 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060264.pdf [firstpage_image] =>[orig_patent_app_number] => 352552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361557 [patent_doc_number] => 06274139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Topoisomerase I' [patent_app_type] => 1 [patent_app_number] => 9/340479 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21878 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274139.pdf [firstpage_image] =>[orig_patent_app_number] => 340479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151197 [patent_doc_number] => 06156310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Topoisomerase III' [patent_app_type] => 1 [patent_app_number] => 9/310669 [patent_app_country] => US [patent_app_date] => 1999-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19260 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156310.pdf [firstpage_image] =>[orig_patent_app_number] => 310669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418826 [patent_doc_number] => 06177257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy' [patent_app_type] => 1 [patent_app_number] => 9/294384 [patent_app_country] => US [patent_app_date] => 1999-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8034 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177257.pdf [firstpage_image] =>[orig_patent_app_number] => 294384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4100908 [patent_doc_number] => 06100091 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Modified acyl-ACP desaturase' [patent_app_type] => 1 [patent_app_number] => 9/276295 [patent_app_country] => US [patent_app_date] => 1999-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15621 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100091.pdf [firstpage_image] =>[orig_patent_app_number] => 276295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4116003 [patent_doc_number] => 06071734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'HBV polymerase, RNase H enzyme derived from HBV polymerase, processes for preparation and uses for screening antiviral agents thereof' [patent_app_type] => 1 [patent_app_number] => 9/228243 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 8484 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071734.pdf [firstpage_image] =>[orig_patent_app_number] => 228243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129195 [patent_doc_number] => 06033900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Enzyme with rhamnogalacturonase activity' [patent_app_type] => 1 [patent_app_number] => 9/201505 [patent_app_country] => US [patent_app_date] => 1998-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14540 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033900.pdf [firstpage_image] =>[orig_patent_app_number] => 201505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4289985 [patent_doc_number] => 06180334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems' [patent_app_type] => 1 [patent_app_number] => 9/176228 [patent_app_country] => US [patent_app_date] => 1998-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 7 [patent_no_of_words] => 7460 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180334.pdf [firstpage_image] =>[orig_patent_app_number] => 176228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935341 [patent_doc_number] => 05989554 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications' [patent_app_type] => 1 [patent_app_number] => 9/174060 [patent_app_country] => US [patent_app_date] => 1998-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22859 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989554.pdf [firstpage_image] =>[orig_patent_app_number] => 174060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009532 [patent_doc_number] => 05962417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Methods of modulating melanin synthesis' [patent_app_type] => 1 [patent_app_number] => 9/160126 [patent_app_country] => US [patent_app_date] => 1998-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6888 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962417.pdf [firstpage_image] =>[orig_patent_app_number] => 160126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4233949 [patent_doc_number] => 06165765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'DNA polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides' [patent_app_type] => 1 [patent_app_number] => 9/157397 [patent_app_country] => US [patent_app_date] => 1998-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16274 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165765.pdf [firstpage_image] =>[orig_patent_app_number] => 157397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920641 [patent_doc_number] => 05951979 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Substrate trapping protein tyrosine phosphatases' [patent_app_type] => 1 [patent_app_number] => 9/144925 [patent_app_country] => US [patent_app_date] => 1998-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 2 [patent_no_of_words] => 23849 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/951/05951979.pdf [firstpage_image] =>[orig_patent_app_number] => 144925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240987 [patent_doc_number] => 06090919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'FACS-optimized mutants of the green fluorescent protein (GFP)' [patent_app_type] => 1 [patent_app_number] => 9/135418 [patent_app_country] => US [patent_app_date] => 1998-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7290 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090919.pdf [firstpage_image] =>[orig_patent_app_number] => 135418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937097 [patent_doc_number] => 05972896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Antiangiogenic peptides and methods for inhibiting angiogenesis' [patent_app_type] => 1 [patent_app_number] => 9/131995 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22196 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972896.pdf [firstpage_image] =>[orig_patent_app_number] => 131995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213433 [patent_doc_number] => 06087108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'RNA editing enzyme' [patent_app_type] => 1 [patent_app_number] => 9/128395 [patent_app_country] => US [patent_app_date] => 1998-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19461 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087108.pdf [firstpage_image] =>[orig_patent_app_number] => 128395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4148310 [patent_doc_number] => 06106828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Conjugation of polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/123787 [patent_app_country] => US [patent_app_date] => 1998-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13452 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/106/06106828.pdf [firstpage_image] =>[orig_patent_app_number] => 123787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975632 [patent_doc_number] => 05958405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Human protein tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 9/123851 [patent_app_country] => US [patent_app_date] => 1998-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 5 [patent_no_of_words] => 16616 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958405.pdf [firstpage_image] =>[orig_patent_app_number] => 123851 [rel_patent_id] =>[rel_patent_doc_number] =>)